Cetera Advisor Networks LLC Vertex Pharmaceuticals Inc Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $3.86 Million - $4.22 Million	9,463 Added 71.76%	22,650 $9.47 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $231,182 - $276,798	674 Added 5.39%	13,187 $5.37 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $665,538 - $713,321	1,968 Added 18.66%	12,513 $4.35 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $994,824 - $1.11 Million	-3,164 Reduced 23.08%	10,545 $3.71 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $620,273 - $707,589	2,190 Added 19.01%	13,709 $4.32 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.28 Million - $1.44 Million	4,488 Added 63.83%	11,519 $3.33 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $102,412 - $114,268	374 Added 5.62%	7,031 $2.04 Million
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $39,943 - $49,733	170 Added 2.62%	6,657 $1.88 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $421,583 - $496,886	1,904 Added 41.54%	6,487 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $67,440 - $85,134	381 Added 9.07%	4,583 $1.01 Million
Q3 2021 Nov 16, 2021	BUY	$181.39 - $202.99 $27,571 - $30,854	152 Added 3.75%	4,202 $762,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $114,931 - $135,534	613 Added 17.84%	4,050 $817,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $10,558 - $12,306	-51 Reduced 1.46%	3,437 $739,000
Q4 2020 Feb 17, 2021	SELL	$207.01 - $276.09 $6,003 - $8,006	-29 Reduced 0.82%	3,488 $824,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $121,178 - $143,669	-474 Reduced 11.88%	3,517 $957,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $77,790 - $102,051	345 Added 9.46%	3,991 $1.16 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $199 - $247	1 Added 0.03%	3,646 $868,000
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $105,694 - $141,958	634 Added 21.06%	3,645 $800,000
Q3 2019 Nov 06, 2019	BUY	$166.23 - $187.09 $53,359 - $60,055	321 Added 11.93%	3,011 $513,000
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $70,453 - $81,478	428 Added 18.92%	2,690 $490,000
Q1 2019 May 06, 2019	BUY	$163.73 - $194.7 $122,470 - $145,635	748 Added 49.41%	2,262 $413,000
Q4 2018 Feb 15, 2019	SELL	$151.91 - $192.21 $232,726 - $294,465	-1,532 Reduced 50.3%	1,514 $251,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $510,905 - $587,086	3,046 New	3,046 $589,000
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $266,667 - $311,026	-1,830 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $9,702 - $11,336	64 Added 3.62%	1,830 $299,000
Q4 2017 Feb 08, 2018	BUY	$137.28 - $155.55 $41,184 - $46,665	300 Added 20.46%	1,766 $263,000
Q3 2017 Nov 16, 2017	SELL	$148.13 - $162.24 $17,034 - $18,657	-115 Reduced 7.27%	1,466 $222,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,581	1,581 $207,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Account